Early-onset (<28 years) primary dystonia in most Ashkenazi Jews is due
to a single founder mutation in the DYT1 gene on chromosome 9q34, as
determined by very strong linkage disequilibrium with a haplotype of 9
q34 alleles at surrounding marker loci. The role of this mutation in i
ndividuals with secondary causes for dystonia has never been tested, a
lthough environmental insults, such as neuroleptic exposure or perinat
al asphyxia, are proposed to precipitate dystonia in genetically predi
sposed individuals. We assessed 9q34 haplotypes in 40 Ashkenazi patien
ts with secondary dystonia; 25 had early onset of symptoms, including
15 with exposure to neuroleptic medication or perinatal asphyxia. Of t
he 25 patients with early onset, 9 were considered phenocopies of DYT1
having normal examinations except for dystonia, normal radiographic a
nd other laboratory studies, and onset in a limb or the neck. Only one
individual whose dystonia developed in the setting of a measles infec
tion carried the associated haplotype. Our findings indicate that clin
ical diagnostic criteria that include historical information to detect
tardive dystonia and perinatal asphyxia discriminate primary dystonia
due to the DYT1 founder mutation. We found no evidence that the DYT1
founder mutation contributes to secondary dystonia.